C David Hastings
Affiliations
- Chief Financial Officer at Arbutus Biopharma Corp (ABUS), 2025-02-19
- at Scynexis Inc (SCYX), 2024-06-21
- Director at Vascular Biogenics Ltd. (VBLT), 2023-01-04
- Director at Entasis Therapeutics Holdings Inc. (ETTX), 2022-07-11
- See Remarks at Unilife Corp (UNIS), 2017-01-31
- Chief Financial Officer at Incyte Corp (INCY), 2014-06-06
Insider Trading: Purchases See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| SCYX | $1.69 | 11,834 | $19,999.46 | 31,834 | 2018-03-08 | Filing |
| SCYX | $1.75 | 20,000 | $35,000.00 | 20,000 | 2017-06-21 | Filing |
| INCY | $10.24 | 2,000 | $20,480.00 | 8,500 | 2010-07-01 | Filing |
Insider Trading: Sales See All
| Symbol | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| ABUS | $3.28 | 22,183 | $72,826.79 | 159,724 | 2025-02-04 | Filing |
| ABUS | $2.31 | 9,593 | $22,183.81 | 181,907 | 2024-02-02 | Filing |
| INCY | $52.81 | 123,966 | $6,546,644.46 | 8,500 | 2014-06-05 | Filing |
| INCY | $52.61 | 76,034 | $4,000,148.74 | 8,500 | 2014-06-04 | Filing |
| INCY | $65.64 | 32,001 | $2,100,545.64 | 8,500 | 2014-02-18 | Filing |